By Gina Shaw
The battle over the beleaguered federal 340B drug discount program continues to rage in Washington as stakeholders argue about the implementation of the final rule.
The Senate Health, Education, Labor and Pensions Committee held its third hearing on oversight of the program on June 19, this one featuring testimony from Capt. Krista M. Pedley, PharmD, MS, the director of the Office of Pharmacy Affairs, for the Healthcare Systems Bureau of the Health Resources and Services